Robertson N - Search Results

1

Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.

Nasir M, Hone L, Tallantyre E, Kelly P, Leite MI, Robertson N, Bestwick J, Huda S, Palace J, Dobson R. Nasir M, et al. Among authors: robertson n. Mult Scler Relat Disord. 2024 May;85:105528. doi: 10.1016/j.msard.2024.105528. Epub 2024 Mar 7. Mult Scler Relat Disord. 2024. PMID: 38479046 Free article.

2

Autism and intellectual disability.

Tallantyre E, Robertson NP. Tallantyre E, et al. J Neurol. 2013 Mar;260(3):936-9. doi: 10.1007/s00415-013-6861-y. J Neurol. 2013. PMID: 23423245 No abstract available.

3

The aetiology of acute neurological decline in multiple sclerosis: experience from an open-access clinic.

Tallantyre EC, Causon EG, Harding KE, Pickersgill TP, Robertson NP. Tallantyre EC, et al. Mult Scler. 2015 Jan;21(1):67-75. doi: 10.1177/1352458514538333. Epub 2014 Jun 18. Mult Scler. 2015. PMID: 24948684

4

Acute stroke management.

Tallantyre EC, Robertson NP. Tallantyre EC, et al. Among authors: robertson np. J Neurol. 2015 Jan;262(1):239-42. doi: 10.1007/s00415-014-7607-1. J Neurol. 2015. PMID: 25504307 No abstract available.

5

Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.

Palace J, Duddy M, Bregenzer T, Lawton M, Zhu F, Boggild M, Piske B, Robertson NP, Oger J, Tremlett H, Tilling K, Ben-Shlomo Y, Dobson C. Palace J, et al. Lancet Neurol. 2015 May;14(5):497-505. doi: 10.1016/S1474-4422(15)00018-6. Epub 2015 Apr 1. Lancet Neurol. 2015. PMID: 25841667

6

Traumatic brain injury: pathophysiology, clinical outcome and treatment.

Williams OH, Tallantyre EC, Robertson NP. Williams OH, et al. Among authors: robertson np. J Neurol. 2015 May;262(5):1394-6. doi: 10.1007/s00415-015-7741-4. J Neurol. 2015. PMID: 25904204 No abstract available.

7

How to run a multiple sclerosis relapse clinic.

Tallantyre EC, Wardle M, Robertson NP. Tallantyre EC, et al. Pract Neurol. 2016 Feb;16(1):62-9. doi: 10.1136/practneurol-2015-001214. Epub 2015 Nov 11. Pract Neurol. 2016. PMID: 26558643 Free PMC article. No abstract available.

8

Continuous evolution of magnetic resonance imaging in multiple sclerosis.

Tallantyre EC, Robertson NP. Tallantyre EC, et al. Among authors: robertson np. J Neurol. 2016 Apr;263(4):835-7. doi: 10.1007/s00415-016-8099-y. J Neurol. 2016. PMID: 27037802 Free PMC article. No abstract available.

9

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.

Hakobyan S, Luppe S, Evans DR, Harding K, Loveless S, Robertson NP, Morgan BP. Hakobyan S, et al. Mult Scler. 2017 Jun;23(7):946-955. doi: 10.1177/1352458516669002. Epub 2016 Sep 9. Mult Scler. 2017. PMID: 27613120

10

Multiple sclerosis: long-term outcomes in ethnic minorities. Analysis of a UK population-based registry.

Alsaeed MO, Harding KE, Williams OH, Willis MD, Hrastelj J, Tallantyre EC, Joseph FG, Wardle M, Pickersgill TP, Robertson NP. Alsaeed MO, et al. Among authors: robertson np. Eur J Neurol. 2018 Apr;25(4):701-704. doi: 10.1111/ene.13571. Epub 2018 Feb 16. Eur J Neurol. 2018. PMID: 29338105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,365 results

Search Page

Filters